• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rgnef 促进卵巢肿瘤的进展,并赋予其对氧化应激的保护作用。

Rgnef promotes ovarian tumor progression and confers protection from oxidative stress.

机构信息

Moores Cancer Center, Department of Obstetrics, Gynecology and Reproductive Science, UC San Diego Health, La Jolla, CA, 92093, USA.

Biomedical Sciences Graduate Program, UC San Diego Health, La Jolla, CA, 92093, USA.

出版信息

Oncogene. 2019 Sep;38(36):6323-6337. doi: 10.1038/s41388-019-0881-8. Epub 2019 Jul 15.

DOI:10.1038/s41388-019-0881-8
PMID:31308489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252434/
Abstract

Ovarian cancer is the fifth-leading cause of cancer death among women. The dissemination of ovarian tumors and growth as spheroids accompanies late-stage disease. In cell culture, ovarian tumor cell spheroids can exhibit elevated resistance to environmental stressors, such as reactive oxygen species. Homeostatic balance of the antioxidant response is a protective mechanism that prevents anoikis, a form of programmed cell death. Signaling pathways activated by integrin receptors suppress anoikis. Rgnef (ARHGEF28/p190RhoGEF) is a guanine nucleotide exchange factor that is activated downstream of integrins. We find that Rgnef protein levels are elevated in late-stage serous ovarian cancer, high Rgnef mRNA levels are associated with decreased progression-free and overall survival, and genomic ARHGEF28 loss is associated with increased patient survival. Using transgenic and transplantable Rgnef knockout mouse models, we find that Rgnef is essential for supporting three-dimensional ovarian spheroid formation in vitro and tumor growth in mice. Using RNA-sequencing and bioinformatic analyses, we identify a conserved Rgnef-supported anti-oxidant gene signature including Gpx4, Nqo1, and Gsta4; common targets of the NF-kB transcription factor. Antioxidant treatment enhanced growth of Rgnef-knockout spheroids and Rgnef re-expression facilitated NF-κB-dependent tumorsphere survival. These studies reveal a new role for Rgnef in ovarian cancer to facilitate NF-κB-mediated gene expression protecting cells from oxidative stress.

摘要

卵巢癌是女性癌症死亡的第五大主要原因。卵巢肿瘤的扩散和球体生长伴随着晚期疾病。在细胞培养中,卵巢肿瘤细胞球体可以表现出对环境应激物(如活性氧)的更高抗性。抗氧化反应的动态平衡是一种保护机制,可防止细胞凋亡,即程序性细胞死亡的一种形式。整合素受体激活的信号通路抑制细胞凋亡。Rgnef(ARHGEF28/p190RhoGEF)是一种鸟嘌呤核苷酸交换因子,可被整合素激活。我们发现 Rgnef 蛋白水平在晚期浆液性卵巢癌中升高,高 Rgnef mRNA 水平与无进展生存期和总生存期缩短相关,而基因组 ARHGEF28 缺失与患者生存率提高相关。使用转基因和可移植的 Rgnef 敲除小鼠模型,我们发现 Rgnef 对于支持体外三维卵巢球体形成和小鼠肿瘤生长是必需的。通过 RNA 测序和生物信息学分析,我们确定了一个保守的 Rgnef 支持的抗氧化基因特征,包括 Gpx4、Nqo1 和 Gsta4;NF-κB 转录因子的常见靶标。抗氧化治疗增强了 Rgnef 敲除球体的生长,而 Rgnef 的重新表达促进了 NF-κB 依赖性肿瘤球体的存活。这些研究揭示了 Rgnef 在卵巢癌中的新作用,以促进 NF-κB 介导的基因表达,从而保护细胞免受氧化应激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/7071d356bfd0/nihms-1581619-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/ce5b7e956dda/nihms-1581619-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/3323e6b7f0d6/nihms-1581619-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/6fada2b9b669/nihms-1581619-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/fb01e9b17981/nihms-1581619-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/60ffdb4c4d29/nihms-1581619-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/714f55629c9c/nihms-1581619-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/7071d356bfd0/nihms-1581619-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/ce5b7e956dda/nihms-1581619-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/3323e6b7f0d6/nihms-1581619-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/6fada2b9b669/nihms-1581619-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/fb01e9b17981/nihms-1581619-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/60ffdb4c4d29/nihms-1581619-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/714f55629c9c/nihms-1581619-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b85f/7252434/7071d356bfd0/nihms-1581619-f0007.jpg

相似文献

1
Rgnef promotes ovarian tumor progression and confers protection from oxidative stress.Rgnef 促进卵巢肿瘤的进展,并赋予其对氧化应激的保护作用。
Oncogene. 2019 Sep;38(36):6323-6337. doi: 10.1038/s41388-019-0881-8. Epub 2019 Jul 15.
2
Rgnef (p190RhoGEF) knockout inhibits RhoA activity, focal adhesion establishment, and cell motility downstream of integrins.Rgnef(p190RhoGEF)敲除抑制整合素下游的 RhoA 活性、焦点黏附形成和细胞迁移。
PLoS One. 2012;7(5):e37830. doi: 10.1371/journal.pone.0037830. Epub 2012 May 23.
3
Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans.人类低分子量神经丝蛋白(NFL)信使核糖核酸(mRNA)与人类中一种预测的p190Rho鸟苷酸交换因子(RhoGEF)同源物(RGNEF)相互作用。
Amyotroph Lateral Scler. 2010;11(1-2):97-103. doi: 10.3109/17482960902995584.
4
Gastrin-stimulated Gα13 Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells.胃泌素刺激下DLD-1结肠癌细胞中Rgnef蛋白(ArhGEF28)的Gα13激活
J Biol Chem. 2015 Jun 12;290(24):15197-209. doi: 10.1074/jbc.M114.628164. Epub 2015 Apr 28.
5
Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.LKB1-NUAK1 信号丢失增强了高级别浆液性卵巢癌球体模型中的 NF-κB 活性。
Sci Rep. 2022 Feb 22;12(1):3011. doi: 10.1038/s41598-022-06796-2.
6
Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.αv 整联蛋白介导的细胞周期停滞或存活信号、PKC 和 ERK1/2 的激活导致卵巢癌细胞球体的抗失巢凋亡能力。
Exp Cell Res. 2014 Jan 15;320(2):329-42. doi: 10.1016/j.yexcr.2013.11.011. Epub 2013 Nov 27.
7
Rho guanine nucleotide exchange factor (RGNEF) is a prosurvival factor under stress conditions.Rho鸟嘌呤核苷酸交换因子(RGNEF)是应激条件下的一种促生存因子。
Mol Cell Neurosci. 2017 Jul;82:88-95. doi: 10.1016/j.mcn.2017.05.003. Epub 2017 May 8.
8
Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.核因子-κB的抑制通过p53非依赖途径增强了源自低级别乳头状浆液性癌的卵巢癌细胞系的肿瘤生长。
BMC Cancer. 2016 Aug 2;16:582. doi: 10.1186/s12885-016-2617-2.
9
The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.致癌性高尔基磷酸蛋白 3 样过表达与卵巢癌顺铂耐药相关,并激活 NF-κB 信号通路。
J Exp Clin Cancer Res. 2017 Oct 4;36(1):137. doi: 10.1186/s13046-017-0607-0.
10
Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.环氧化酶 2 通过 PGE2/NF-κB 通路促进卵巢癌细胞的增殖和侵袭。
Cell Transplant. 2019 Dec;28(1_suppl):1S-13S. doi: 10.1177/0963689719890597. Epub 2019 Dec 10.

引用本文的文献

1
Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type.单细胞RNA测序揭示了高钙血症型卵巢小细胞癌的肿瘤内异质性和免疫微环境。
J Ovarian Res. 2025 Apr 9;18(1):76. doi: 10.1186/s13048-025-01649-8.
2
Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy.卵巢癌的治疗靶点:纳米增强型CRISPR/Cas9基因编辑与联合药物治疗
Int J Nanomedicine. 2025 Mar 30;20:3907-3931. doi: 10.2147/IJN.S507688. eCollection 2025.
3
Guanine nucleotide exchange factors and colon neoplasia.

本文引用的文献

1
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?在卵巢癌中,干性和化疗耐药性能否通过信号通路进行治疗性靶向干预?
Cancers (Basel). 2018 Jul 24;10(8):241. doi: 10.3390/cancers10080241.
2
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer.多细胞脱离在卵巢上皮癌腹腔内播散过程中产生转移性球体。
Oncogene. 2018 Sep;37(37):5127-5135. doi: 10.1038/s41388-018-0317-x. Epub 2018 May 23.
3
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
鸟嘌呤核苷酸交换因子与结肠肿瘤形成
Front Cell Dev Biol. 2024 Oct 18;12:1489321. doi: 10.3389/fcell.2024.1489321. eCollection 2024.
4
Ascitic Shear Stress Activates GPCRs and Downregulates Mucin 15 to Promote OvarianCancer Malignancy.腹水剪切应力激活G蛋白偶联受体并下调黏蛋白15以促进卵巢癌恶性进展。
Res Sq. 2024 Nov 25:rs.3.rs-5160301. doi: 10.21203/rs.3.rs-5160301/v1.
5
Anoikis in cell fate, physiopathology, and therapeutic interventions.细胞命运、生理病理学及治疗干预中的失巢凋亡
MedComm (2020). 2024 Sep 15;5(10):e718. doi: 10.1002/mco2.718. eCollection 2024 Oct.
6
Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer.非小细胞肺癌中新型氧化应激和失巢凋亡相关预后标志物的鉴定及其免疫图谱分析。
Int J Mol Sci. 2023 Nov 10;24(22):16188. doi: 10.3390/ijms242216188.
7
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances.核因子-κB在细胞死亡、肿瘤治疗耐药性及纳米治疗中的研究进展
Pharmaceuticals (Basel). 2023 May 24;16(6):783. doi: 10.3390/ph16060783.
8
The Role of NQO1 in Ovarian Cancer.NQO1 在卵巢癌中的作用。
Int J Mol Sci. 2023 Apr 25;24(9):7839. doi: 10.3390/ijms24097839.
9
The Emerging Role of m6A Modification in Endocrine Cancer.m6A修饰在内分泌癌中的新兴作用
Cancers (Basel). 2023 Feb 6;15(4):1033. doi: 10.3390/cancers15041033.
10
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.高级别浆液性卵巢癌细胞的转移能力随疾病进展而变化:米非司酮的抑制作用。
Cancer Cell Int. 2022 Dec 9;22(1):397. doi: 10.1186/s12935-022-02822-5.
NEDD9 促进致癌信号、干细胞/间充质基因特征以及促进小鼠卵巢癌的生长。
Oncogene. 2018 Aug;37(35):4854-4870. doi: 10.1038/s41388-018-0296-y. Epub 2018 May 18.
4
NRF2 and the Hallmarks of Cancer.NRF2 与癌症的特征。
Cancer Cell. 2018 Jul 9;34(1):21-43. doi: 10.1016/j.ccell.2018.03.022. Epub 2018 May 3.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Rho guanine nucleotide exchange factor (RGNEF) is a prosurvival factor under stress conditions.Rho鸟嘌呤核苷酸交换因子(RGNEF)是应激条件下的一种促生存因子。
Mol Cell Neurosci. 2017 Jul;82:88-95. doi: 10.1016/j.mcn.2017.05.003. Epub 2017 May 8.
7
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.miRpower:一种利用2178例乳腺癌患者的表达数据来验证与生存相关的微小RNA的网络工具。
Breast Cancer Res Treat. 2016 Dec;160(3):439-446. doi: 10.1007/s10549-016-4013-7. Epub 2016 Oct 15.
8
Small-Molecule Protein-Protein Interaction Inhibitor of Oncogenic Rho Signaling.致癌性 Rho 信号小分子蛋白-蛋白相互作用抑制剂。
Cell Chem Biol. 2016 Sep 22;23(9):1135-1146. doi: 10.1016/j.chembiol.2016.07.015. Epub 2016 Sep 1.
9
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.卵巢癌患者输卵管中SOX2的癌前过表达:发现与验证研究。
EBioMedicine. 2016 Aug;10:137-49. doi: 10.1016/j.ebiom.2016.06.048. Epub 2016 Jul 2.
10
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.人类高级别浆液性卵巢癌的综合蛋白质基因组特征分析
Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29.